TNF and neoplasm: Research has revealed that TNF-α induces diverse oncogenic and tumor-suppressive effects in TME (12) and that dynamic changes in TME could influence the pharmacological action of PD-1/PD ligand 1 (PD-L1) blockers, potentially developing immunotherapy tolerance (13).